Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial
- 1 August 2005
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 366 (9484), 463-471
- https://doi.org/10.1016/s0140-6736(05)67060-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Outpatient antibiotic use in Europe and association with resistance: a cross-national database studyThe Lancet, 2005
- Approach to resistant gram-negative bacterial pulmonary infections in patients with cystic fibrosisCurrent Opinion in Pulmonary Medicine, 2003
- Defining a pulmonary exacerbation in cystic fibrosisThe Journal of Pediatrics, 2001
- Single versus combination intravenous antibiotic therapy for people with cystic fibrosisPublished by Wiley ,2001
- Managing Antibiotic ResistanceNew England Journal of Medicine, 2000
- Multiple Combination Bactericidal Antibiotic Testing for Patients with Cystic Fibrosis Infected with Multiresistant Strains of Pseudomonas aeruginosaAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Multiple Combination Bactericidal Antibiotic Testing for Patients with Cystic Fibrosis Infected with Burkholderia cepaciaAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Comparison of a β-lactam alone versus β-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosisThe Journal of Pediatrics, 1999
- Antibiotic Susceptibility of Multiply Resistant Pseudomonas aeruginosa Isolatedfrom Patients with Cystic Fibrosis, Including Candidates for TransplantationClinical Infectious Diseases, 1996
- Reduction of SputumPseudomonas aeruginosaDensity by Antibiotics Improves Lung Function in Cystic Fibrosis More than Do Bronchodilators and Chest Physiotherapy AloneAmerican Review of Respiratory Disease, 1990